Published on
00:17 GMT
Rewrite Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy this news headline ...
image: Figure 3: CNS disease response on amivantamab. MRI Brain at the time of pre-treatment (A(i–iv)), 6 months (B(i–iv)), 19 months (C(i–iv)) post-treatment demonstrating complete resolution of CNS disease at 6 months (B(i–iv)), and 19 months (C(i–iv)). …
Source:
Bioengineer.org
-
Indeterminate
.jpg)
